When O 2 availability is reduced unavoidably, as it is at high altitude, a potential mechanism to improve O 2 delivery to tissues is an increase in blood flow. Nitric oxide (NO) regulates blood vessel diameter and can influence blood flow. This field study of intrapopulation variation at high altitude tested the hypothesis that the level of exhaled NO (a summary measure of pulmonary synthesis, consumption, and transfer from cells in the airway) is directly proportional to pulmonary, and thus systemic, blood flow. Twenty Tibetan male and 37 female healthy, nonsmoking, native residents at 4,200 m (13,900 ft), with an average O 2 saturation of hemoglobin of 85%, participated in the study. The geometric mean partial pressure of NO exhaled at a flow of 17 ml/s was 23.4 nmHg, significantly lower than that of a sea-level reference group. However, the rate of NO transfer out of the airway wall was seven times higher than at sea level, which implied the potential for vasodilation of the pulmonary blood vessels. Mean pulmonary blood flow (measured by cardiac index) was 2.7 Ϯ 0.1 (SE) l/min, and mean pulmonary artery systolic pressure was 31.4 Ϯ 0.9 (SE) mmHg. Higher exhaled NO was associated with higher pulmonary blood flow; yet there was no associated increase in pulmonary artery systolic pressure. The results suggest that NO in the lung may play a key beneficial role in allowing Tibetans at 4,200 m to compensate for ambient hypoxia with higher pulmonary blood flow and O 2 delivery without the consequences of higher pulmonary arterial pressure. high altitude; oxygen delivery; oxygen availability; hypoxia WHEN OXYGEN AVAILABILITY is reduced, as it is at high altitude, an increased blood flow could potentially improve O 2 delivery to tissues. However, the pulmonary vasoconstriction response to hypoxia decreases blood flow in the lung, the first point of contact with the circulation. This response probably evolved at sea level to maintain gas exchange by redistribution of blood flow from temporarily small, poorly oxygenated to betteroxygenated areas of the lung (17, 32). At high altitude, the entire lung is always hypoxic, and the resulting general vasoconstriction does not redistribute blood flow; instead, it increases pulmonary arterial pressure, sometimes causing pathological remodeling of the heart and lungs (30). However, many people live at high altitude without pulmonary hypertension or cardiac hypertrophy, which suggests that another factor may intervene to maintain blood flow when the blood carries less O 2 and the usual vasoconstriction response increases pulmonary resistance. That factor may be nitric oxide (NO), a vasodilator found in high concentrations in the lungs of high-altitude natives, particularly among Tibetans (5).
WHEN OXYGEN AVAILABILITY is reduced, as it is at high altitude, an increased blood flow could potentially improve O 2 delivery to tissues. However, the pulmonary vasoconstriction response to hypoxia decreases blood flow in the lung, the first point of contact with the circulation. This response probably evolved at sea level to maintain gas exchange by redistribution of blood flow from temporarily small, poorly oxygenated to betteroxygenated areas of the lung (17, 32) . At high altitude, the entire lung is always hypoxic, and the resulting general vasoconstriction does not redistribute blood flow; instead, it increases pulmonary arterial pressure, sometimes causing pathological remodeling of the heart and lungs (30) . However, many people live at high altitude without pulmonary hypertension or cardiac hypertrophy, which suggests that another factor may intervene to maintain blood flow when the blood carries less O 2 and the usual vasoconstriction response increases pulmonary resistance. That factor may be nitric oxide (NO), a vasodilator found in high concentrations in the lungs of high-altitude natives, particularly among Tibetans (5) .
A wealth of studies support a key role for NO in determining basal pulmonary vascular tone at sea level and in effecting the hypoxic vasoconstriction response. An animal study using NO synthase gene transfer to the airway demonstrates elegantly that increasing NO decreases hypoxic pulmonary vasoconstriction (7) . Studies of humans are consistent and have demonstrated that 1) NO is critical in regulating basal pulmonary vascular tone (10, 27) , 2) inhibiting NO synthesis exacerbates hypoxic pulmonary vasoconstriction, and 3) inhaling gas mixtures with high concentrations of NO diminishes hypoxic pulmonary vasoconstriction at sea level (6, 15) and lowers pulmonary artery systolic pressure at high altitude (23) . Moreover, sea-level natives exposed to acute hypoxia (and who have relatively high levels of exhaled NO) have less hypoxic pulmonary vasoconstriction, as measured by pulmonary artery systolic pressure (8, 11) . This physiological evidence justifies an examination of the relation between NO and pulmonary blood flow in the normal range of variation among healthy high-altitude natives. Accordingly, we tested the hypothesis that the level of exhaled NO, a summary measure of pulmonary synthesis, consumption, and transfer of NO, is directly related to pulmonary blood flow measured by cardiac index in a sample of healthy Tibetans, native residents at 4,200 m.
METHODS
Population and sample. The research described here adheres to the principles of the Declaration of Helsinki and Title 45 of the US Code of Federal Regulations, Part 46, Protection of Human Subjects. The Institutional Review Board of Case Western Reserve University approved the protocol, and informed consent was obtained.
Data for this field study were collected from June to August 2002 in Panam Xiang, a rural agropastoral district of Xigatse Prefecture, Tibet Autonomous Region, at 4,200 m. From a total of 98 volunteers, 88 normotensive, nonanemic, nonsmoking, healthy (by self-report), nonpregnant (by self-report) high-altitude native 18-to 55-yr-old Tibetans with normal pulmonary function provided demographic information along with measures of exhaled NO. Eighty individuals (91%) volunteered for an echocardiographic examination 3-5 wk later. Of these 80 volunteers, 3 had heart disease (mild pulmonic stenosis, mild mitral stenosis, or small secundum atrial septal defect) and 12 did not have a tricuspid regurgitant jet adequate for estimation of pulmonary artery systolic pressure. Thus 65 (81%) individuals were free of any abnormalities on echo-Doppler examination and had a tricuspid regurgitant jet adequate for pulmonary hemodynamic estimates. Four determinations of exhaled NO were lost because of machine error, and four subjects did not provide technically acceptable efforts. Thus 57 (87% of those with an adequate echocardiogram) had technically acceptable measurements of exhaled NO and comprise the study sample described in Table 1 . The reported sample of 57 and the larger samples of 80 with echocardiography and 88 healthy individuals differed by Ͻ1% in the mean values of the cardiopulmonary and exhaled NO variables reported here.
The reference group comprised 20 (7 men and 13 women) healthy (by self-report), nonsmoking, nonasthmatic sea-level residents. For men, the average age was 47 Ϯ 15 yr, height 1.76 Ϯ 0.07 m, and weight 80.4 Ϯ 12.2 kg; for women, the average age was 39 Ϯ 13 yr, height 1.66 Ϯ 0.08 m, and weight 68.6 Ϯ 12.3 kg.
Measurements. The fraction of NO in exhaled breath was measured using an online method in parts per billion with an NO analyzer (Sievers NOA 280i, Ionics Instruments, Boulder, CO) that has a sensitivity of Ͻ1 ppb and uses a chemiluminescent technique. Nasal NO contamination was minimized by a standardized procedure in which the subject exhales against an expiratory resistance (10 -20 cmH 2O), which causes velum closure (3, 16) and generates a plateau level of NO. The exhaled NO reported is the average of three exhalations at a given flow rate. If the three values were not within 2 ppb of each other, then a fourth measurement was collected and the three most similar values were averaged. Two-point calibrations were performed once or twice a day using a Zero Air Filter (Ionics Instruments) to provide an air sample free of NO and a gas with a known concentration of NO [45 ppm (Ionics Instruments) or 9.4 ppm (Praxair, Cleveland, OH)]. The ambient conditions at the time of morning calibrations were as follows: 14.4°C average temperature, 52% relative humidity, 1.3 ppb NO in ambient air, and 464 Torr barometric pressure. To take into account the lower barometric pressure for comparisons with sea-level data, NO measured in parts per billion (the fractional concentration) was converted to NO in nanometers Hg [i.e., partial pressure (PNO)] by multiplying by barometric pressure minus 47 mmHg (i.e., water vapor pressure at 37°C in the lung) and dividing by 1,000. Variability between NO measurements over time is 6.6 Ϯ 1.4% (13) .
Pulmonary artery hemodynamics were measured noninvasively using echocardiography. Echocardiographic studies were performed with an Acuson Cypress ultrasonograph (Siemens Medical Solutions). Standard parasternal, apical, and subcostal two-dimensional views were obtained, and color flow-directed pulsed-wave Doppler measurements of transvalvular flows and continuous-wave Doppler measurements of the tricuspid regurgitant flow were obtained. A single-lead electrocardiogram was recorded on the ultrasonograph. Measures obtained using this noninvasive technique correlate closely with those obtained using cardiac catheterization (2, 18) , an invasive technique that is not appropriate for a field study of healthy individuals in a rural, out-of-hospital setting.
O2 saturation of hemoglobin was measured by pulse oximetry (model 504, Criticare Systems, Waukesha, WI). Hemoglobin concentration was determined in duplicate using the cyanmethemoglobin technique (Hemoglobinometer, Hemocue, Angelholm, Sweden) immediately after a venous blood sample was drawn. Arterial O 2 content (AOC) was calculated in milliliters O2 per 100 ml blood (volume percent) as follows: AOC ϭ 1.39 ϫ (O2 saturation ϫ hemoglobin concentration)/100 (31) . Pulmonary function was assessed by forced vital capacity and forced expiratory volume at 1 s (QRS Diagnostic Spirocard, Plymouth, MN) (4). A determination was the best of three measurements. Reported blood pressures are averages of three resting, seated determinations.
Analyses. Pulmonary artery systolic pressure (PASP) was calculated as follows
where TR vel is tricuspid regurgitation jet velocity and RAP is the estimated right atrial pressure based on the respiration variation in inferior vena cava size (20) . Cardiac output (CO) was calculated as follows
where P(D/2) 2 is the cross-sectional area of blood flow into the aorta, Aovti is the velocity time integral through the aorta, and HR is heart rate.
In the absence of shunts and significant regurgitation, cardiac output is equal to pulmonary blood flow. To control for variation in body size, cardiac index was calculated as cardiac output divided by body surface area calculated from height and weight.
Total pulmonary resistance (PR) was measured as follows
NO exchange in the lung was analyzed using a theoretical twocompartment model of pulmonary NO that includes a distal alveolar component and an airway component (26, 29) and provides estimates of NO concentration in the airway wall (nmHg), transfer rate of NO from the airway wall (nl ⅐ s Ϫ1 ⅐ mmHg Ϫ1 ), and maximum potential airway flux of NO (nl/s). In the model, exhaled NO is primarily affected by NO concentration in the airway wall and the rate of NO transfer from the wall to the airway lumen; both can be estimated from measurements of exhaled NO at two or more flow rates (i.e., 17 and 50 ml/s). A two-point linear regression is used to estimate the airway wall NO content and the NO transfer rate. For each subject, exhaled NO (ppb) at each flow rate is plotted against the elimination rate of NO, which is determined by the product of exhaled NO concentration and flow rate (17 or 50 ml/s). The slope of the line provides the transfer rate of NO, and the y-intercept provides the airway wall NO content. The amount of NO that enters the airstream from the airways per unit time during exhalation is the NO flux, which can be calculated mathematically as the product of airway wall NO content and transfer rate of NO.
Multiple linear regression models (SPSS version 11) were used to predict cardiac index, pulmonary artery systolic pressure, and total pulmonary resistance; variables included age, gender (and their interaction), exhaled NO, and O 2 saturation. Dependent and independent variables used in the multiple regression were first subjected to bivariate correlative analysis. Natural logarithmic transformation normalized the distribution of NO exhaled at 17 and 50 ml/s as well as the variables derived from these direct measures. Statistical analyses were performed on the transformed values; results are presented in the original units. Geometric means (the natural antilogarithm of the natural logarithmically transformed mean) are reported for those variables. The dispersions about the geometric means were expressed in terms of the standard deviations of the transformed means. Coef- ficients of variation were calculated as 100 ϫ (transformed standard deviation/transformed mean). Means Ϯ SE are reported for other variables. Data from controls and Tibetans were compared with an unpaired t-test. A significance level of P Ͻ 0.05 is accepted.
RESULTS
Pulmonary hemodynamics. Pulmonary blood flow measured as cardiac output was 3.9 Ϯ 0.1 (SE) l/min (range 2.6 -6.5), and mean cardiac index (which takes body size into account) was 2.7 Ϯ 0.1 (SE) l⅐min Ϫ1 ⅐m Ϫ2 (range 1.9 -4.6). The average pulmonary artery systolic pressure was 31.5 Ϯ 1.0 (SE) mmHg (range 17.2-55.9). Pulmonary artery systolic pressure of 39 subjects (68%) was within the normal sea-level range of Ͻ35 mmHg (1), while the values for the remaining subjects were higher. The mean calculated total pulmonary resistance was 8.5 Ϯ 0.4 (SE) mmHg/l (range 4.1-19.4). There were no gender differences or correlations with age among these variables.
Exhaled NO and kinetics. Exhaled NO was not associated with age or gender differences, body size, systemic blood pressure, forced vital capacity, hemoglobin concentration, or inflammation measured by the level of C-reactive protein. At exhalation of 17 ml/s, the mean PNO of 23.4 nmHg among the Tibetans was lower than the mean of 30.7 nmHg for a sea-level reference sample of 20 healthy adults in the United States (Table 2 ). At exhalation of 50 ml/s, the mean PNO of 12.4 nmHg among the Tibetans did not differ from the mean of 13.7 nmHg for the sea-level sample (Table 2 ). Altitude differences in PNO of exhaled breath could result from differences in NO concentration in the airway wall or in the transfer rate of NO from the airway wall to the airway lumen. The mean calculated NO concentration of 39.8 nmHg in the airway wall in the Tibetan sample at 4,200 m was lower than the mean of 104.3 nmHg for the sea-level control sample ( Table 2 ). The lower NO concentration in the airway wall may be due to the O 2 dependency of NO synthase kinetics, leading to a lower rate of synthesis (12), a greater NO consumption, or a faster rate of NO transfer out of the airway wall. The average NO transfer rate of 0.07 nl⅐s Ϫ1 ⅐mmHg Ϫ1 in the Tibetan sample was seven times higher than that among the sea-level controls ( Table 2) . As a result, the maximum potential NO flux (product of airway wall NO content and diffusion or transfer rate of NO out of the airway wall) of 2.8 nl/s in the Tibetan sample was more than double the sea-level reference average of 1.2 ml/s, despite the lower exhaled NO and NO concentration in the airway wall (Table 2) . NO flux was significantly and inversely related to pulmonary resistance (r ϭ Ϫ0.243, P ϭ 0.041); inasmuch as both variables were normally distributed, transformation was unnecessary. Thus the implication for blood flow and O 2 delivery is that NO, which diffuses in all directions, is not only transferred to the airway lumen at a higher rate but is probably also transferred to the pulmonary arteries (which subsequently vasodilate) at a higher rate.
Multiple regression models. To address the hypothesis that higher NO levels augmented pulmonary blood flow, Table 3 presents the bivariate correlation matrix for variables used in regression models summarized in Table 4 . Heart rate was not correlated with NO (r ϭ 0.11, P ϭ 0.39); therefore, it was not used in the multiple regression analysis.
Higher NO was associated with higher cardiac index (Fig.  1A) and lower pulmonary vascular resistance (Fig. 2) , consistent with the hypothesis. Age and gender alone accounted for ϳ20% of the variance in cardiac index; exhaled NO explained an additional 10% of the variance (Table 4 ). Age and gender accounted for ϳ5% of the variance in total pulmonary resistance; exhaled NO accounted for an additional ϳ8% of the variance. However, these factors did not explain variance in pulmonary artery systolic pressure.
Greater physiological hypoxia, as measured by lower O 2 saturation of hemoglobin, was associated with higher pulmonary artery systolic pressure, consistent with the presence of varying degrees of hypoxic pulmonary vasoconstriction. O 2 saturation, as well as age, gender, and NO, explained ϳ13% of the variance in pulmonary artery systolic pressure compared with the model without saturation, which did not explain any variance (Table 4 ). Higher saturation and increased exhaled NO are associated with lower pulmonary resistance; O 2 saturation, along with age, gender, and NO, explained ϳ21% of the variance in pulmonary resistance (compared with the model using just age, gender, and NO, which explained ϳ13% of the variance). These data suggest that, although they are modest, the effects of NO and O 2 saturation on pulmonary resistance and pulmonary artery systolic pressure are additive and independent.
DISCUSSION
The main finding of this field study of hypoxic, high-altitude native Tibetans residing at 4,200 m is that higher levels of NO in the normal range of variation were associated with higher pulmonary blood flow measured by cardiac index. Moreover, these findings suggest that higher NO causes vasodilation, which allows greater pulmonary blood flow, cardiac output, ); PASP, pulmonary artery systolic pressure (mmHg); PVR, total pulmonary resistance (mmHg/l). *P Ͻ 0.05 (2-tailed test). †0.05 Ͻ P Ͻ 0.10 (2-tailed test).
and O 2 delivery to the systemic circulation without elevated pulmonary artery systolic pressure. An individual in the 75th percentile of exhaled NO has ϳ12% higher pulmonary blood flow than an individual in the 25th percentile yet does not have higher pulmonary artery systolic pressure as a result, because pulmonary resistance is lower.
Several lines of evidence support the reasoning that elevated NO allows higher cardiac index. 1) Exhaled NO does not increase after experimental elevation of cardiac output (12) . 2) Exhaled NO is decreased on acute exposure to high altitude, despite elevation of cardiac output (11, 23, 30) . 3) Experimental inhibition of NO synthesis causes a decrease in cardiac index at sea level (6, 27) . Taken together, these findings suggest that increases in NO result in a higher cardiac output or cardiac index. An alternative interpretation of the association between NO and cardiac index in this Tibetan sample is that Model with O2 Sat and exhaled NO Regression models explain variability in cardiac index (CI), pulmonary artery systolic pressure (PASP), and pulmonary resistance (PR) of Tibetan high-altitude native residents of 4,200 m. The first category for each dependent variable indicates variability accounted for by age, gender, and their interaction. The category for each dependent variable indicates variability accounted for after addition to the regression model of the natural logarithm of exhaled NO measured at 17 ml/s. The difference in R 2 of 2 categories measures the independent contribution of exhaled NO to variability in the dependent variable. MSE, mean square error. increases in cardiac output cause shear stress, which induces NO synthesis. This seems unlikely in light of the cited evidence showing that changes in NO precede changes in cardiac output or cardiac index. Other things being equal, higher cardiac output might even lower NO if it causes recruitment and perfusion of blood vessels in which NO output could be scavenged by circulating hemoglobin, instead of being exhaled. NO delivery from the circulation to the lung is discounted, because hemoglobin inactivates NO (21) and because direct measurement of bronchiolar gases showed that alveolar NO was virtually nil (12, 24) . NO concentration in exhaled breath is dependent on exhalation flow rate (19, 25) . A two-compartment model explains the exhalation flow rate dependence of NO concentration. As air passes through the airways, the gas is infused, with NO diffusing from the airway wall. The lower the exhalation flow rate, the longer the time that the gases passing over the airway wall will be infused with NO from the airway wall; hence, the exhaled NO will be higher. Similar to previous studies (16, 25) , the low flow of 17 ml/s is the most sensitive here, inasmuch as it reveals that Tibetans have slightly less exhaled NO than controls at sea level. [Analyses performed with the 50 ml/s flow rate revealed similar, significant correlations (data not shown).] Possible explanations for the low NO concentration among the high-altitude Tibetans include downregulation of synthesis, higher consumption, or faster rate of transfer from the airway wall. The transfer rate of 0.07 nl⅐s Ϫ1 ⅐ mmHg Ϫ1 is 7-10 times higher than the range of 0.004 -0.013 nl⅐s Ϫ1 ⅐mmHg Ϫ1 reported for sea-level samples, including our sea-level control (16) . According to Fick's law, transfer (diffusion) is directly proportional to the PNO difference between the airway wall and lumen and to the area over which diffusion takes place. Because the PNO difference between the cell wall and the airway lumen is relatively small at altitude, the implication is that the higher transfer rate is achieved because transfer is taking place over a larger area. For example, NO synthesis may be extended to more airways in this population (S. Permutt, personal communication). The result is a maximum potential NO flux in this Tibetan sample that is nearly double that at sea level, which is consistent with our previous report that Tibetans accumulated more than twice as much NO as sea-level controls during a 15-s breath hold: 7.6 vs. 3.9 nmHg (5).
The initial impetus for the study was the inverse relation between pulmonary NO and pulmonary arterial pressure found in animal and human experiments (6, 7, 9, 14, 15, 22, 23, 27, 28) . That relation was not found in this study, despite adequate statistical power. Different study designs may be responsible. This high-altitude field study of Tibetans examined the normal range of variation in NO, whereas the sea-level studies used experimental interventions with large effects, such as inhibition of NO synthesis or addition of large doses of inhaled NO, to markedly change pulmonary NO and, as a result, change pulmonary artery systolic pressure.
The results of this study show two independent influences on the lung of Tibetans at high altitude. Lower O 2 saturation of hemoglobin is associated with higher pulmonary artery systolic pressure (consistent with hypoxic pulmonary vasoconstriction). Higher NO allows greater pulmonary blood flow measured by cardiac index but does not increase pulmonary artery systolic pressure, presumably because NO causes dilation of pulmonary blood vessels and reduces pulmonary resistance. This independent effect of NO reduces the chance of a potential cost of higher pulmonary blood flow, i.e., higher pulmonary artery systolic pressure, which could cause pathologies including right ventricular hypertrophy and muscularization of the pulmonary arteries (30) .
Several limitations merit comment. 1) The number of Tibetan men is relatively small. The requirement for nonsmoking in the population unfortunately excluded most Tibetan adult men. A related problem is the lack of correlation between cardiac index and exhaled NO in men. The significant interaction between age and gender in the models incorporating O 2 saturation requires further study, inasmuch as there are too few men to reach a definite conclusion; indeed, the sample size lacks sufficient power to test any specific gender effect.
2) The effect of NO is modest. However, there is clearly an additive and independent effect that is important in such a complex system. 3) Mathematical modeling for NO exchange is not without limitations; e.g., it is possible that the model may not be valid at high altitude, even though we account for the lower barometric pressure in the comparisons of high-altitude with sea-level data. 4) The study design and the limitations of field work do not permit distinction between genetic and/or acquired altitude-mediated mechanisms. 5) The reference group is not a true control group. However, the reference group was included to emphasize and illustrate further the distinctiveness of the population that resides in a stressful environment.
Nevertheless, our findings support the possibility that, in the normal range of variation of exhaled NO among Tibetans residing at 4,200 m, high NO may partly compensate for ambient hypoxia and low arterial O 2 content by allowing higher pulmonary blood flow and, thus, greater O 2 delivery to working tissues.
